|Genomics & Big Data Summit|
Metabolomics - Advances & Applications in Human Disease
Next Generation Sequencing
Big Data Bioinformatics
CRISPR & Genome Engineering
The CRISPR & Genome Engineering Conference is part of The Genomics & Big Data Summit and will bring together an exciting balance of industry and academia, so that delegates have the unique opportunity to network with colleagues from different sectors and discuss the most recent advances in CRISPR & Genome Engineering.
Leading researchers will present on hot topics such as: therapeutic applications of CRISPR and genome engineering, discovery and mechanisms of CRISPR systems, and will discuss updates on current CRISPR technologies and techniques. In addition to scientific talks, dedicated networking sessions will allow attendees to better dialogue on how CRISPR & Genome Engineering will continue to impact biomedical research.
Joint Plenary Sessions:
- Opening Keynote Session – Historical Perspective & Current State of the Industry
- Round Table Discussions
- Lunch Session – Ethical Challenges of Big Data and Genomics Application
- Award Ceremony & Closing Keynote Session – Predictions for the Future
CRISPR & Genome Engineering:
- CRISPR Technologies and Regulation of Gene Expression
- Therapeutic Applications of CRISPR and Genome Engineering
We look forward to seeing you at the conference!
The 2017 Advisory Committee
Amber Kempf at 626-256-6405 or amber.kempf [at] gtcbio.com
Cancer Genetics Inc. (CGI; Nasdaq: CGIX) is a leader in enabling precision medicine in oncology from bench to bedside through the use of oncology biomarkers and molecular testing. CGI is developing a global footprint with locations in the US, India and China. The Company offers a comprehensive range of laboratory services that provide critical genomic and biomarker information. Its state-of-the-art reference labs are CLIA-certified and CAP-accredited in the US and have licensure from several states including New York State. CGI has established strong clinical research collaborations with major cancer centers such as Memorial Sloan Kettering, The Cleveland Clinic, Mayo Clinic, Keck School of Medicine at USC and the National Cancer Institute.